Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 19,423 $ 13,724
Investments 139,939 7,182
Restricted cash 285 192
Prepaid expenses and other current assets 1,243 2,448
Total current assets 160,890 23,546
Restricted cash 385 478
Property and equipment, net 519 973
Operating lease right of use assets 2,377 3,063
Other assets 0 212
Total assets 164,171 28,272
Current liabilities:    
Notes payable 0 301
Accounts payable 2,887 3,179
Accrued expenses 7,176 11,030
Derivative liability 0 39
Operating lease liabilities, current 1,562 1,437
Loan payable 0 15,908
Total current liabilities 11,625 31,894
Other long-term liabilities 0 44
Operating lease liabilities, noncurrent 2,048 3,239
Total liabilities 13,673 35,177
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at September 30, 2024 and December 31, 2023. 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized,12,179,482 and 4,423,683 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 1 0
Additional paid-in capital 617,653 429,780
Accumulated deficit (467,363) (436,684)
Accumulated other comprehensive gain (loss) 207 (1)
Total stockholders equity (deficit) 150,498 (6,905)
Total liabilities and stockholders’ equity $ 164,171 $ 28,272